VANCOUVER, British Columbia, Canada – Precision NanoSystems, Inc. (PNI), a privately held biotechnology company developing proprietary microfluidic-based manufacturing technology for the use and development of cutting edge nanomedicines, has been invited to speak at the 2013 International Liposome Society (ILS) Meeting, Liposome Advances: Progress in Drug and Vaccine Delivery, to be held in London, UK from 14 – 17 December 2013.  Dr. James Taylor, Chief Executive Officer of PNI, will present PNI’s recent advances in the development and use of the NanoAssemblr^TM Platform for the rapid development and scale-up of lipid nanoparticle drugs.  Dr. Taylor’s presentation, “The NanoAssemblr^TM Platform : Microfluidics-Based Manufacture of Nanomedicines” will be held on December 17 at 11am.

Dr. Taylor commented, “The ILS meeting is long-standing conference exhibiting work from world-wide leaders in lipid nanoparticles. The NanoAssemblr platform is setting the standard for lipid nanoparticle development, with many ILS members now using the NanoAssemblr^TM platform. The NanoAssemblr^TMtechnology enables exquisite control over nanoparticle formation for expedited development and manufacture of previously unobtainable next-generation lipid nanoparticles.  This includes “limit-size” lipid nanoparticle systems designed to facilitate improved delivery of bioactive materials to a wider range of cells and tissues in the body.”

About Precision NanoSystems, Inc.

At Precision NanoSystems we are creating innovative tools for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research. Our proprietary NanoAssemblr platform enables the simple, rapid, reproducible, and scalable manufacture of next-generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to difficult-to-access cells and tissues in the body. We provide instruments, reagents and services to life sciences researchers and build strategic collaborations to revolutionize healthcare through nanotechnology. To join the revolution visit our website.

About the 2013 International Liposomal Society Meeting

The 2013 ILS Annual meeting will deal with recent progress in lipid nanoparticle research and applications. It will cover topics as diverse as interaction of liposomes with the biological milieu, cancer and antimicrobial therapy, conventional and genetic vaccines, topical applications, gene therapy, and RNA interference. Clinical, industrial and regulatory aspects will also be included. It is anticipated that the conference will, as previously, attract worldwide interest.